Ardent Health Partners, Inc. (ARDT) Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
USD 21.12
(+68.12%)
Based on the Ardent Health Partners, Inc. stock forecast from 9 analysts, the average analyst target price for Ardent Health Partners, Inc. is USD 21.12 over the next 12 months. Ardent Health Partners, Inc.’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Ardent Health Partners, Inc. is Slightly Bearish, which is based on 3 positive signals and 4 negative signals. At the last closing, Ardent Health Partners, Inc.’s stock price was USD 12.56. Ardent Health Partners, Inc.’s stock price has changed by +0.40% over the past week, -4.92% over the past month and 0% over the last year.
No recent analyst target price found for Ardent Health Partners, Inc.
No recent average analyst rating found for Ardent Health Partners, Inc.
Company Overview Ardent Health Partners, Inc.
Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. The company offers both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C. Read Less
Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. The company offers both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthope...Read More
Frequently Asked Questions About Ardent Health Partners, Inc. (ARDT) Stock
Based on ratings from 9 analysts Ardent Health Partners, Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 12 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on ARDT's stock to indicate if its a good dividend stock.
Based on targets from 9 analysts, the average taret price for ARDT is USD 21.12 over the next 12 months. The maximum analyst target price is USD 25 while the minimum anlayst target price is USD 16.
ARDT stock's Price/Earning ratio is 30.76.
Our analysis grades ARDT stock's Price / Earning ratio at F. This means that ARDT stock's Price/Earning ratio is above 88% of the stocks in the Medical Care Facilities sector in the NYE exchange.
Based on this ARDT may be a overvalued for its sector.
The last closing price of ARDT's stock was USD 12.56.
The most recent market capitalization for ARDT is USD 2.59B.
Based on targets from 9 analysts, the average taret price for ARDT is projected at USD 21.12 over the next 12 months.
This means that ARDT's stock price may go up by +68.12% over the next 12 months.
We can't find any ETFs which contains Ardent Health Partners, Inc.'s stock.
As per our most recent records Ardent Health Partners, Inc. has 19,200 Employees.
Ardent Health Partners, Inc.'s registered address is 340 Seven Springs Way, Brentwood, TN, United States, 37027.
You can get more information about it from Ardent Health Partners, Inc.'s website at https://www.ardenthealth.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Ardent Health Partners, Inc. (ARDT) Stock
Based on ratings from 9 analysts Ardent Health Partners, Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 12 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on ARDT's stock to indicate if its a good dividend stock.
Based on targets from 9 analysts, the average taret price for ARDT is USD 21.12 over the next 12 months. The maximum analyst target price is USD 25 while the minimum anlayst target price is USD 16.
ARDT stock's Price/Earning ratio is 30.76.
Our analysis grades ARDT stock's Price / Earning ratio at F. This means that ARDT stock's Price/Earning ratio is above 88% of the stocks in the Medical Care Facilities sector in the NYE exchange.
Based on this ARDT may be a overvalued for its sector.
The last closing price of ARDT's stock was USD 12.56.
The most recent market capitalization for ARDT is USD 2.59B.
Based on targets from 9 analysts, the average taret price for ARDT is projected at USD 21.12 over the next 12 months.
This means that ARDT's stock price may go up by +68.12% over the next 12 months.
We can't find any ETFs which contains Ardent Health Partners, Inc.'s stock.
As per our most recent records Ardent Health Partners, Inc. has 19,200 Employees.
Ardent Health Partners, Inc.'s registered address is 340 Seven Springs Way, Brentwood, TN, United States, 37027.
You can get more information about it from Ardent Health Partners, Inc.'s website at https://www.ardenthealth.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ARDT !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
